Nitrazepam Dak

Nitrazepam, the active ingredient in Nitrazepam Dak, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed for the short‑term management of insomnia, anxiety disorders, and as an adjunct in epilepsy therapy.

GNH USA supplies Nitrazepam Dak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrazepam belongs to the benzodiazepine class and is used to treat disorders of the central nervous system that involve excessive neuronal excitability. - Insomnia: helps initiate and maintain sleep in patients with difficulty sleeping. - Anxiety disorders: reduces excessive worry and tension by producing a calming effect. - Adjunct therapy for epilepsy: lowers the frequency of seizure activity when added to standard antiepileptic regimens.

Nitrazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Dizziness: light‑headed sensation or loss of balance. - Headache: mild to moderate cranial pain. - Fatigue: reduced energy and motivation. - Cognitive impairment: difficulty concentrating or remembering. - Muscle weakness: reduced muscular strength.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Paradoxical aggression: unexpected agitation or hostility. - Dependence or withdrawal: physical reliance after prolonged use. - Depression or suicidal thoughts: mood changes requiring immediate attention. - Hepatic dysfunction: abnormal liver enzyme levels.

Nitrazepam should be used with caution and under medical supervision. - Assess renal and hepatic function: adjust use if impairment is present. - Avoid abrupt discontinuation: taper dose to prevent withdrawal symptoms. - Limit use in the elderly: increased sensitivity to sedation and falls. - Do not combine with alcohol or other CNS depressants: risk of profound sedation. - Counsel patients on operating machinery: avoid driving or hazardous tasks until effects are known. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nitrazepam can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: additive respiratory depression and profound sedation. - Other benzodiazepines: excessive CNS depression and risk of overdose. - Barbiturates: synergistic depressant effects on the central nervous system.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase sedation. - Antihistamines: enhanced drowsiness. - Antiepileptic drugs (phenytoin, carbamazepine): may reduce nitrazepam plasma levels. - CYP3A4 inhibitors (ketoconazole, erythromycin): can raise nitrazepam concentrations.